Display omitted
•Various bioanalytical method validation guidelines have been issued worldwide by different regulatory agencies.•This review provides summary to evaluate the different guidelines ...during bioanalytical method development and validation.•Different evaluation parameters such as matrix effect, incurred sample reanalysis and various stability aspects with an easy way for designing the bioanalytical method validation have been discussed.
The concepts, importance, and application of bioanalytical method validation have been discussed for a long time and validation of bioanalytical methods is widely accepted as pivotal before they are taken into routine use. United States Food and Drug Administration (USFDA) guidelines issued in 2001 have been referred for every guideline released ever since; may it be European Medical Agency (EMA) Europe, National Health Surveillance Agency (ANVISA) Brazil, Ministry of Health and Labour Welfare (MHLW) Japan or any other guideline in reference to bioanalytical method validation. After 12 years, USFDA released its new draft guideline for comments in 2013, which covers the latest parameters or topics encountered in bioanalytical method validation and approached towards the harmonization of bioanalytical method validation across the globe. Even though the regulatory agencies have general agreement, significant variations exist in acceptance criteria and methodology. The present review highlights the variations, similarities and comparison between bioanalytical method validation guidelines issued by major regulatory authorities worldwide. Additionally, other evaluation parameters such as matrix effect, incurred sample reanalysis including other stability aspects have been discussed to provide an ease of access for designing a bioanalytical method and its validation complying with the majority of drug authority guidelines.
Isoflavonoids are the biologically active secondary metabolites of plants that are being used for several health promoting and restoring effects mediated through different pathways. Isoflavonoids are ...structurally similar to estrogens due to which also known as phytoestrogens and have shown potent estrogenic and anti-estrogenic activity. Association with large biological activity lead to the need of rapid, sensitive and precise quantitation of different isoflavonoids in different plant extracts, food materials and biological matrices as the biological activities mainly depends on the quantities and nature of isoflavonoids present in them. The characterisation, standardisation and quantification of herbal extracts or food products require techniques that are highly selective, sensitive and also provide mass measurement precisions and structural information. Liquid chromatography with tandem mass spectroscopy has made it possible to analyse and characterize several constituents and their metabolites in a single run along with high selectivity and sensitivity. In this review, we have summarised the application of LC–MS/MS for the identification and quantification of isoflavonoids reported for various plant extracts and food products along with their general extraction procedures and factors affecting extraction providing a view towards the conditions used for their analysis. The most suitable and widely acceptable extraction solvent system for the isoflavonoids is methanol or ethanol in combination with water ranging from 40 to 60 % organic solvent based on the type of tissues and the isoflavonoids to be extracted by different extraction techniques. ESI ionization with Q-TOF MS was the most useful detection system for the characterisation and quantification of the diverse isoflavonoids with molecular insights.
•First technical review summarizing bioanalytical LC methods for antitubercular drugs till date.•Bioanalytical liquid chromatographic methods for anti-TB drugs are discussed.•Focus is on sample ...preparation, separation and sensitivity of the anti-TB drugs.•This will serve as a one-stop guide for future TB drug bioanalysis.
Tuberculosis is a life threatening disease and second to HIV in terms of deaths due to infectious diseases. Drug resistance development of the first-line drugs is a major concern in the treatment of this disease. There is no comprehensive and critical review in the literature of the bioanalytical methods for the determination of anti-tubercular agents from last two decades. This work offers a detailed account on the liquid chromatographic methods reported in the literature for the estimation of various anti-tubercular drugs. Major emphasis is given to sample preparation process, sensitivity of method, chromatographic separation conditions and detection systems used in their bioanalysis.
The main objective of medicinal chemistry is to synthesize compounds that show promising activity as therapeutic agents with lower toxicity. Thiazolidinone and Pyrazoline derivatives may show ...different activities, such as analgesic, anti-inflammatory, antitubercular activities etc. Mannich base derivatives of Thiazolidinones from Schiff bases have been synthesized by reacting them with previously prepared Pyrazolines from Chalocnes, with the yield ranging from 56% to 71%. The identification and characterization of the prepared compounds were carried out by melting point, TLC, FT-IR, 1H-NMR, to ascertain that all prepared compounds were of different chemical nature, than the respective parent compound. The synthesized compounds were evaluated for angiotensin II blocking activity, and were found to show significant results.
Organic–inorganic hybrid perovskite materials have recently attracted extensive interest to develop next-generation high efficiency optoelectronic devices. However, in many of these devices, ...perovskite thin films are the key source of photogenerated electron and hole pairs. Therefore, a strategy for the preparation of high-quality perovskite thin films with a fewer number of traps at surfaces and grain boundaries is highly desired. In this work, sulfur-doped graphene quantum dots (S-GQDs) were synthesized and incorporated in the CH
3
NH
3
PbBr
3
perovskite precursor to prepare S-GQDs incorporated perovskite thin films. The as-prepared thin films were systematically characterized using X-ray diffractometer, field emission scanning electron microscope, UV–Vis and fluorescence spectrophotometer to investigate the effect of different amounts of S-GQDs on their morphology, optical absorbance and electron transfer properties. The experimental findings revealed that multiple surface functional groups, quantum confinement and desirable electronic conductivity in S-GQDs help passivate the perovskite surface by reducing the surface and grain boundary traps. Interestingly, the incorporation of S-GQDs increased the light absorption of CH
3
NH
3
PbBr
3
along with faster electron transfer across their interfaces. Hence, this strategy of S-GQDs incorporation presents a versatile and novel way to prepare highly efficient perovskite thin films for developing next-generation solar cells, light emitting diodes and other optoelectronic devices.
The programmed fabrication of oral dosage forms is associated with several challenges such as controlled loading and disintegration. To optimize the drug payload, excipient breakdown, and ...site-specific sustained release of hydrophobic drug (sulfamethoxazole, SM), we propose the development of acrylate polymer tablets enclosed with drug-loaded polycaprolactone (PCL) films. The active pharmaceutical ingredient (API) is physisorbed into the porous iron (Fe)-based metal-organic framework (MOF) and later converted to tangible PCL films, which, upon folding, are incorporated into the acrylate polymer matrices (P1/P2/P3). X-ray powder diffraction (XRPD) analysis and scanning electron microscopy (SEM) micrographs confirmed the stability and homogeneous distribution of MOF within the 50 μm thick film. Adsorption-desorption measurements at ambient temperatures confirmed the decrease in the BET surface area of PCL films by 40%, which was ∼3.01 m/g, and pore volume from 30 to 9 nm. The decrease in adsorption and surface parameters could confirm the gradual accessibility of SM molecules once exposed to a degrading environment. Fourier transform infrared (FTIR) analyses of in vitro dissolution confirmed the presence of the drug in the MOF-PCL film-enclosed tablets and concluded the cumulative SM release at pH ∼ 8.2 which followed the order SM@Fe-MOF < P1/P2/P3 < PCL-SM@Fe-MOF < P1/PCL-SM@Fe-MOF < P3/PCL-SM@Fe-MOF. The results of the study indicate that the P3/PCL-SM@Fe-MOF assembly has potential use as a biomedical drug delivery alternative carrier for effective drug loading and stimuli-responsive flexible release to attain high bioavailability.The programmed fabrication of oral dosage forms is associated with several challenges such as controlled loading and disintegration. To optimize the drug payload, excipient breakdown, and site-specific sustained release of hydrophobic drug (sulfamethoxazole, SM), we propose the development of acrylate polymer tablets enclosed with drug-loaded polycaprolactone (PCL) films. The active pharmaceutical ingredient (API) is physisorbed into the porous iron (Fe)-based metal-organic framework (MOF) and later converted to tangible PCL films, which, upon folding, are incorporated into the acrylate polymer matrices (P1/P2/P3). X-ray powder diffraction (XRPD) analysis and scanning electron microscopy (SEM) micrographs confirmed the stability and homogeneous distribution of MOF within the 50 μm thick film. Adsorption-desorption measurements at ambient temperatures confirmed the decrease in the BET surface area of PCL films by 40%, which was ∼3.01 m/g, and pore volume from 30 to 9 nm. The decrease in adsorption and surface parameters could confirm the gradual accessibility of SM molecules once exposed to a degrading environment. Fourier transform infrared (FTIR) analyses of in vitro dissolution confirmed the presence of the drug in the MOF-PCL film-enclosed tablets and concluded the cumulative SM release at pH ∼ 8.2 which followed the order SM@Fe-MOF < P1/P2/P3 < PCL-SM@Fe-MOF < P1/PCL-SM@Fe-MOF < P3/PCL-SM@Fe-MOF. The results of the study indicate that the P3/PCL-SM@Fe-MOF assembly has potential use as a biomedical drug delivery alternative carrier for effective drug loading and stimuli-responsive flexible release to attain high bioavailability.
Neurilemmoma of cervical sympathetic chain Singla, Sham L; Kadian, Yogender Singh; Malhotra, Naveen ...
Indian Journal of Otolaryngology and Head and Neck Surgery
56, Številka:
2
Journal Article
Recenzirano
Odprti dostop
Neurilemmoma of the cervical sympathetic chain is a rare nerve tumour. Less than 40 confirmed cases have been reported in the literature.1 2 Sometimes they can he mistaken as carotid body tumour but ...usual presentation of these lesions is an asymptomatic neck mass. Because of the rarity of the tumour we report another case of neurilemmoma arising from cervical sympathetic chain in a 19 years old male.